Indeed, while the majority of cells constituting the tumor mass demonstrate the loss of the wild-type BRCA1 allele, there is a small fraction of BRCA1-proficient malignant cells which are resistant to therapeutic pressure and undergo expansion during NACT [21]. The gene discussed is BRCA1; the disease is neoplasm.